Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Fosun Pharma Partners with Fakeeh Care Group to Advance Biopharmaceuticals in Saudi Arabia
April 30, 2025
Company
Fosun Pharma Reports Q1 2025 Revenues of RMB 9.42 Billion, Net Profits of RMB 765 Million
April 30, 2025
Company
Medical Device
Roche’s VENTANA TROP2 Device Receives FDA Breakthrough Designation
April 30, 2025
Company
Drug
Hengrui Pharmaceuticals Receives NMPA Clearance for HRS-5635 in Chronic HBV
April 30, 2025
Company
Deals
Fosun Pharma’s Henlius Strikes Deal with Sandoz for Global Rights to HLX13 Biosimilar
April 30, 2025
Legal / IP
BeiGene Wins USPTO Ruling Invalidating Pharmacyclics’ Patent Claims
April 30, 2025
Company
AstraZeneca’s Q1 2025 Results: 10% Revenue Growth, Oncology Segment Shines
April 30, 2025
Company
Pfizer’s Q1 2025 Results: Revenues Down 6% YOY Amid Paxlovid, IRA Impact
April 30, 2025
Company
United Imaging Healthcare Reports 9.73% Revenue Decline in 2024 Financials
April 29, 2025
Company
Deals
Innovent Biologics Expands Clinical Partnership with ImmVirX to Include Hepatocellular Carcinoma
April 29, 2025
Company
Drug
Boehringer Ingelheim’s Zongertinib Shows Promising Results in HER2-Mutant NSCLC Trial
April 29, 2025
Company
Drug
Kangpu Biopharmaceuticals Receives NMPA Approval for KPG-818 Phase IIb Study in SLE
April 29, 2025
1
2
…
175
176
177
178
179
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
